The US withdrew from treaty negotiations on President Trump’s first day in office.
- Professor of Philosophy, Binghamton University, State University of New York
USAID has a decades-long history of fighting smallpox, polio, malaria, tuberculosis and HIV.
At a moment of soul-searching about health care in the US, an expert on global health puts the American system in perspective.
Listen to experts discuss the business practices of pharmaceutical companies in The Conversation Weekly podcast.
‘Orphan drugs’ with high price points are being tested as treatments for COVID-19. There’s a better way to spur low-cost innovation for new drugs.
Los acuerdos paralelos firmados por algunos países ricos amenazan con socavar los esfuerzos mundiales para garantizar un esfuerzo de vacunación mundial equitativo.
Side agreements signed by some wealthy nations threaten to undercut global efforts to ensure a fairly equitable worldwide vaccination effort.
The Trump administration wants to go it alone when it comes to vaccine development and distribution. What does this mean for the U.S. and the world?
A bioethicist explains a recent report that recommends how to distribute a COVID-19 vaccine equitably.
Many of us believe that outrage is an appropriate response to what appears to be a selfishly motivated refusal to wear a mask, but is it?
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
In the future, consumers in the developed world could choose to purchase products from the companies that do the most to promote global health.
Contact Nicole for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Binghamton, New York, U.S.
- Website
- Article Feed
- Joined
